Literature DB >> 11014734

Fatal rhabdomyolysis associated with simvastatin in a renal transplant patient.

W J Weise, C J Possidente.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014734     DOI: 10.1016/s0002-9343(99)00320-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.

Authors:  Alexandra E Rätz Bravo; Lydia Tchambaz; Anita Krähenbühl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

4.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30

5.  Detection and characterization of simvastatin and its metabolites in rat tissues and biological fluids using MALDI high resolution mass spectrometry approach.

Authors:  Wencui Yin; Reem I Al-Wabli; Mohamed W Attwa; A F M Motiur Rahman; Adnan A Kadi
Journal:  Sci Rep       Date:  2022-03-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.